New Therapeutic Options Could Shift Prostate Cancer Treatment (APAC)
We will discuss the current prostate cancer treatments and key catalysts for older drugs facing loss of exclusivity. We will also discuss new therapies for prostate cancer, with protein degraders and T-cell engagers both aiming to hit the market in the near future.